(VIANEWS) – The NYSE opens in less than four hours and Aurora Cannabis‘s pre-market value is already 5.13% up.
The last session, NYSE finished with Aurora Cannabis (ACB) dropping 1.45% to $0.53. NYSE rose 1.17% to $15,826.35, following the last session’s upward trend on what was an all-around up trend exchanging session.
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Earnings Per Share
As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-6.19.
Sales Growth
Aurora Cannabis’s sales growth is 28.8% for the ongoing quarter and 27.9% for the next.
More news about Aurora Cannabis (ACB).
